Cargando…
Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments
Enterotoxigenic E. coli (ETEC) is a leading cause of moderate-to-severe diarrhoea. ETEC colonizes the intestine through fimbrial tip adhesin colonization factors and produces heat-stable and/or heat-labile (LT) toxins, stimulating fluid and electrolyte release leading to watery diarrhoea. We reporte...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486917/ https://www.ncbi.nlm.nih.gov/pubmed/32983577 http://dx.doi.org/10.1038/s41541-020-00228-w |
_version_ | 1783581401625395200 |
---|---|
author | Poncet, David Hessler, Catherine Liang, Hong Gautheron, Sylviane Sergent, Michelle Rintala, Nicholas D. Seydoux, Emilie Huang, Po-Wei D. Argilla, David Ruiz, Sophie Heinrichs, Jon Maciel, Milton Orr, Mark T. |
author_facet | Poncet, David Hessler, Catherine Liang, Hong Gautheron, Sylviane Sergent, Michelle Rintala, Nicholas D. Seydoux, Emilie Huang, Po-Wei D. Argilla, David Ruiz, Sophie Heinrichs, Jon Maciel, Milton Orr, Mark T. |
author_sort | Poncet, David |
collection | PubMed |
description | Enterotoxigenic E. coli (ETEC) is a leading cause of moderate-to-severe diarrhoea. ETEC colonizes the intestine through fimbrial tip adhesin colonization factors and produces heat-stable and/or heat-labile (LT) toxins, stimulating fluid and electrolyte release leading to watery diarrhoea. We reported that a vaccine containing recombinant colonization factor antigen (CfaEB) targeting fimbrial tip adhesin of the colonization factor antigen I (CFA/I) and an attenuated LT toxoid (dmLT) elicited mucosal and systemic immune responses against both targets. Additionally, the toll-like receptor 4 ligand second-generation lipid adjuvant (TLR4-SLA) induced a potent mucosal response, dependent on adjuvant formulation. However, a combination of vaccine components at their respective individual optimal doses may not achieve the optimal immune profile. We studied a subunit ETEC vaccine prototype in mice using a response surface design of experiments (DoE), consisting of 64 vaccine dose-combinations of CfaEB, dmLT and SLA in four formulations (aqueous, aluminium oxyhydroxide, squalene-in-water stable nanoemulsion [SE] or liposomes containing the saponin Quillaja saponaria-21 [LSQ]). Nine readouts focusing on antibody functionality and plasma cell response were selected to profile the immune response of parenterally administered ETEC vaccine prototype. The data were integrated in a model to identify the optimal dosage of each vaccine component and best formulation. Compared to maximal doses used in mouse models (10 µg CfaEB, 1 µg dmLT and 5 µg SLA), a reduction in the vaccine components up to 37%, 60% and 88% for CfaEB, dmLT and SLA, respectively, maintained or even maximized immune responses, with SE and LSQ the best formulations. The DoE approach can help determine the best vaccine composition with a limited number of experiments and may accelerate development of multi-antigen/component ETEC vaccines. |
format | Online Article Text |
id | pubmed-7486917 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-74869172020-09-24 Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments Poncet, David Hessler, Catherine Liang, Hong Gautheron, Sylviane Sergent, Michelle Rintala, Nicholas D. Seydoux, Emilie Huang, Po-Wei D. Argilla, David Ruiz, Sophie Heinrichs, Jon Maciel, Milton Orr, Mark T. NPJ Vaccines Article Enterotoxigenic E. coli (ETEC) is a leading cause of moderate-to-severe diarrhoea. ETEC colonizes the intestine through fimbrial tip adhesin colonization factors and produces heat-stable and/or heat-labile (LT) toxins, stimulating fluid and electrolyte release leading to watery diarrhoea. We reported that a vaccine containing recombinant colonization factor antigen (CfaEB) targeting fimbrial tip adhesin of the colonization factor antigen I (CFA/I) and an attenuated LT toxoid (dmLT) elicited mucosal and systemic immune responses against both targets. Additionally, the toll-like receptor 4 ligand second-generation lipid adjuvant (TLR4-SLA) induced a potent mucosal response, dependent on adjuvant formulation. However, a combination of vaccine components at their respective individual optimal doses may not achieve the optimal immune profile. We studied a subunit ETEC vaccine prototype in mice using a response surface design of experiments (DoE), consisting of 64 vaccine dose-combinations of CfaEB, dmLT and SLA in four formulations (aqueous, aluminium oxyhydroxide, squalene-in-water stable nanoemulsion [SE] or liposomes containing the saponin Quillaja saponaria-21 [LSQ]). Nine readouts focusing on antibody functionality and plasma cell response were selected to profile the immune response of parenterally administered ETEC vaccine prototype. The data were integrated in a model to identify the optimal dosage of each vaccine component and best formulation. Compared to maximal doses used in mouse models (10 µg CfaEB, 1 µg dmLT and 5 µg SLA), a reduction in the vaccine components up to 37%, 60% and 88% for CfaEB, dmLT and SLA, respectively, maintained or even maximized immune responses, with SE and LSQ the best formulations. The DoE approach can help determine the best vaccine composition with a limited number of experiments and may accelerate development of multi-antigen/component ETEC vaccines. Nature Publishing Group UK 2020-09-11 /pmc/articles/PMC7486917/ /pubmed/32983577 http://dx.doi.org/10.1038/s41541-020-00228-w Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Poncet, David Hessler, Catherine Liang, Hong Gautheron, Sylviane Sergent, Michelle Rintala, Nicholas D. Seydoux, Emilie Huang, Po-Wei D. Argilla, David Ruiz, Sophie Heinrichs, Jon Maciel, Milton Orr, Mark T. Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments |
title | Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments |
title_full | Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments |
title_fullStr | Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments |
title_full_unstemmed | Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments |
title_short | Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments |
title_sort | preclinical optimization of an enterotoxigenic escherichia coli adjuvanted subunit vaccine using response surface design of experiments |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486917/ https://www.ncbi.nlm.nih.gov/pubmed/32983577 http://dx.doi.org/10.1038/s41541-020-00228-w |
work_keys_str_mv | AT poncetdavid preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments AT hesslercatherine preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments AT lianghong preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments AT gautheronsylviane preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments AT sergentmichelle preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments AT rintalanicholasd preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments AT seydouxemilie preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments AT huangpoweid preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments AT argilladavid preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments AT ruizsophie preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments AT heinrichsjon preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments AT macielmilton preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments AT orrmarkt preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments |